CD73 facilitates EMT progression and promotes lung metastases in triple-negative breast cancer
Abstract CD73 is a cell surface ecto-5′-nucleotidase, which converts extracellular adenosine monophosphate to adenosine. High tumor CD73 expression is associated with poor outcome among triple-negative breast cancer (TNBC) patients. Here we investigated the mechanisms by which CD73 might contribute...
Guardado en:
Autores principales: | Nataliia Petruk, Sanni Tuominen, Malin Åkerfelt, Jesse Mattsson, Jouko Sandholm, Matthias Nees, Gennady G. Yegutkin, Arja Jukkola, Johanna Tuomela, Katri S. Selander |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b2c631e7001b40c2910848b8522fac2a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
CD73 is a major regulator of adenosinergic signalling in mouse brain.
por: Natalia Kulesskaya, et al.
Publicado: (2013) -
CD73 Severed as a Potential Prognostic Marker and Promote Lung Cancer Cells Migration via Enhancing EMT Progression
por: Zhao-wei Gao, et al.
Publicado: (2021) -
A high-content image analysis approach for quantitative measurements of chemosensitivity in patient-derived tumor microtissues
por: Ilmari Ahonen, et al.
Publicado: (2017) -
Competitive endogenous RNA is an intrinsic component of EMT regulatory circuits and modulates EMT
por: Yuwei Liu, et al.
Publicado: (2019) -
Acta No. 73
por: Banco Central de Chile
Publicado: (2019)